Risk of virological failure after drug burden reduction in people with 4-class drug-resistant HIV on virological suppression: A retrospective cohort analysis of data from the PRESTIGIO Registry
Tommaso Clemente(Vita-Salute San Raffaele University), Vincenzo Spagnuolo(Vita-Salute San Raffaele University), Andrea Giacomelli(ASST Fatebenefratelli Sacco), Maria Mercedes Santoro(University of Rome Tor Vergata), Adriana Cervo(Azienda Ospedaliero-Universitaria di Modena), Leonardo Calza(University of Bologna), Antonella Castagna(Vita-Salute San Raffaele University), Stefano Rusconi(University of Milan), Marta Fiscon(University of Verona), Franco Maggiolo(Ospedale Papa Giovanni XXIII), Riccardo Lolatto(Vita-Salute San Raffaele University), Sara Diotallevi(Vita-Salute San Raffaele University), Roberta Gagliardini(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)
Cited by 3
Related Papers
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency
|Critical Care and Resuscitation|2020|229
Mpox in people with past infection or a complete vaccination course: a global case series
|The Lancet Infectious Diseases|2023|141
Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis
|Diabetes Care|2021|101
A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2013|41
The HIV Type 1 Epidemic in Bulgaria Involves Multiple Subtypes and Is Sustained by Continuous Viral Inflow from West and East European Countries
|AIDS Research and Human Retroviruses|2008|40